Plain-English translation of NCT05575882 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a moisturizing cream called BI 479 V1 to see if it can help prevent eczema from flaring up in children. Half of the children will receive the actual cream, and half will receive a placebo (a cream with no active ingredients), so researchers can compare how well the real treatment works. The study will follow children for 4 months to see if the medication reduces how often and how severe their eczema becomes.
Eczema is a skin condition that comes and goes in flare-ups, causing itching, irritation, and discomfort. Doctors want to find ways to prevent these flare-ups from happening in the first place, rather than just treating them after they start.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic 5 times over 4 months (at the start, and then at 1, 2, 3, and 4 months). At each visit, a doctor will check your skin and measure how severe your eczema is. At home, you'll apply the study cream twice daily to clean, dry skin using a simple method based on your child's age and height, followed by any other skin treatments your doctor has prescribed. You'll keep track of any flare-ups and follow your normal routines for hygiene and sun protection.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Argentina
India
Singapore